Company Information

  

Address: 10 SYLVAN WAY  
City: PARSIPPANY 
State: NJ 
Zip Code: 07054 
Telephone: 973-822-7000 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

Zoetis Inc. is a global leader in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. We have a diversified business, commercializing products across eight core species: cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals); and within five major product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals. For more than 60 years, we have been committed to enhancing the health of animals and bringing solutions to our customers who raise and care for them. We were incorporated in Delaware in July 2012 and prior to that the company was a business unit of Pfizer Inc. (Pfizer). The address of our principal executive offices is 10 Sylvan Way, Parsippany, New Jersey 07054.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
03/20182.000.12641.76
12/20171.750.12641.17
09/20171.900.10533.56
06/20171.770.10535.24
03/20171.730.10530.85
12/20161.650.10532.44
09/20161.390.09537.42
06/20161.290.09536.79

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2017 Leverage 2017
Net Inc/Comm Equity5.20Total Liab/Total Assets0.79
Net Inc/Total Assets0.10Total Liab/Inv Cap0.91
Net Inc/Inv Cap0.12Total Liab/Comm Equity41.06
Pretax Inc/Net Sales0.29Interest Coverage Ratio9.71
Net Inc/Net Sales0.16Curr Debt/EquityNA
Cash Flow/Net Sales0.25LTD/Equity2.90
SG&A/NetSales0.25Total Debt/Equity2.90
Asset Utilization   Liquidity  
Net Receivables Turnover5.55Quick Ratio2.55
Inventory Turnover1.21Current Ratio3.85
Inventory Day Sales0.00Net Rec/Curr Assets0.24
Net Sales/Work Cap1.70Inv/Curr Assets0.34
Net Sales/PP&E3.70  

Income Statement (Millions)

  3/31/2018 12/31/2017 10/1/2017 7/2/2017
Total Revenues(Net Sales) 1,366.00 1,460.00 1,347.00 1,269.00
Cost of Goods Sold 447.00 457.00 435.00 440.00
Selling & Admin Exps 338.00 361.00 328.00 336.00
Operating Income 459.00 497.00 457.00 384.00
Interest Exp 47.00 50.00 43.00 41.00
Pretax Income 417.00 430.00 413.00 345.00
Other Income 5.00 -17.00 -1.00 2.00
Net Income Bef Extraordinary ... NA NA NA NA
Net Income 352.00 81.00 298.00 247.00

Balance Sheet (Millions)

Assets 3/31/2018 12/31/2017 10/1/2017 7/2/2017
Cash & Short Term Investments 1,654.00 1,564.00 1,981.00 705.00
Receivables - Total 943.00 998.00 1,009.00 975.00
Inventories - Total 1,441.00 1,427.00 1,490.00 1,498.00
Total Current Assets 4,267.00 4,217.00 4,894.00 3,584.00
Net Property, Plant & Equipment 1,453.00 1,435.00 1,388.00 1,355.00
Total Assets 8,690.00 8,586.00 9,288.00 7,802.00
Liabilities        
Accounts Payable 971.00 1,050.00 956.00 902.00
Debt in Current Liabilities NA NA 750.00 850.00
Total Current Liabilities 1,000.00 1,094.00 1,746.00 1,784.00
Long-Term Debt 5,258.00 5,125.00 5,041.00 3,802.00
Total Liabilities 6,730.00 6,816.00 7,299.00 6,087.00
Stockholder's Equity        
Minority Interest 15.00 16.00 30.00 31.00
Preferred Stock 0.00 0.00 0.00 0.00
Common Stock 5.00 5.00 5.00 5.00
Retained Earnings 2,399.00 2,109.00 2,140.00 1,843.00
Treasury Stock -1,005.00 -852.00 -733.00 -615.00
Total Stockholders' Equity 1,960.00 1,770.00 1,989.00 1,715.00
Total Liabilities and Stockholders' Equity 8,690.00 8,586.00 9,288.00 7,802.00

Cash Flow Summary (Millions)

Categories 3/31/2018 12/31/2017 10/1/2017 7/2/2017
Net Cash Provided by Operating Activities 389.00 608.00 439.00 180.00
Net Cash Provided by Investing Activities -45.00 -54.00 -128.00 -40.00
Net Cash Provided by Financing Activities -262.00 -967.00 956.00 -64.00

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/20134,561.00504.001.01
12/20144,785.00583.001.16
12/20154,765.00339.000.68
12/20164,888.00821.001.65
12/20175,307.00864.001.75
Growth Rates3.8614.4214.73

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional06/30/18960442,41691.43




Report Date : 7/10/2018

Powered By Edgar Online © 2018EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.